Home Other Building Blocks 6H-Dibenzo[a,g]quinolizine-2,10-diol, 5,8,13,13a-tetrahydro-3,9-dimethoxy-, (13aS)-

6H-Dibenzo[a,g]quinolizine-2,10-diol, 5,8,13,13a-tetrahydro-3,9-dimethoxy-, (13aS)-

CAS No.:
16562-13-3
Catalog Number:
AG001W9G
Molecular Formula:
C19H21NO4
Molecular Weight:
327.3743
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG001W9G
Chemical Name:
6H-Dibenzo[a,g]quinolizine-2,10-diol, 5,8,13,13a-tetrahydro-3,9-dimethoxy-, (13aS)-
CAS Number:
16562-13-3
Molecular Formula:
C19H21NO4
Molecular Weight:
327.3743
MDL Number:
MFCD00211195
IUPAC Name:
(13aS)-3,9-dimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline-2,10-diol
InChI:
InChI=1S/C19H21NO4/c1-23-18-8-12-5-6-20-10-14-11(3-4-16(21)19(14)24-2)7-15(20)13(12)9-17(18)22/h3-4,8-9,15,21-22H,5-7,10H2,1-2H3/t15-/m0/s1
InChI Key:
JKPISQIIWUONPB-HNNXBMFYSA-N
SMILES:
COc1cc2CCN3[C@H](c2cc1O)Cc1c(C3)c(OC)c(cc1)O
UNII:
0UPX3E69W8
Properties
Complexity:
447  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0
Exact Mass:
327.147g/mol
Formal Charge:
0
Heavy Atom Count:
24  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
327.38g/mol
Monoisotopic Mass:
327.147g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
62.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.6  
Literature
Title Journal
(-)-Stepholidine is a potent pan-dopamine receptor antagonist of both G protein- and β-arrestin-mediated signaling. Psychopharmacology 20150301
Design, synthesis, and pharmacological evaluation of novel tetrahydroprotoberberine derivatives: selective inhibitors of dopamine D₁ receptor. Bioorganic & medicinal chemistry 20120801
l-Stepholidine-induced excitation of dopamine neurons in rat ventral tegmental area is associated with its 5-HT(1A) receptor partial agonistic activity. Synapse (New York, N.Y.) 20110501
L-stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease. Neurobiology of aging 20100601
Enantioselective total synthesis of (-)-(S)-stepholidine. The Journal of organic chemistry 20091204
D(1)/D(2) receptor-targeting L-stepholidine, an active ingredient of the Chinese herb Stephonia, induces non-rapid eye movement sleep in mice. Pharmacology, biochemistry, and behavior 20091101
Evaluation of the antipsychotic effect of bi-acetylated l-stepholidine (l-SPD-A), a novel dopamine and serotonin receptor dual ligand. Schizophrenia research 20091101
Oral bioavailability and brain penetration of (-)-stepholidine, a tetrahydroprotoberberine agonist at dopamine D(1) and antagonist at D(2) receptors, in rats. British journal of pharmacology 20091101
Dibenzazecine scaffold rebuilding--is the flexibility always essential for high dopamine receptor affinities? Bioorganic & medicinal chemistry 20091001
[Five alkaloids from vine stems of Diploclisia affinis]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20081101
The antipsychotic potential of l-stepholidine--a naturally occurring dopamine receptor D1 agonist and D2 antagonist. Psychopharmacology 20080801
Recent development in studies of tetrahydroprotoberberines: mechanism in antinociception and drug addiction. Cellular and molecular neurobiology 20080601
Dopamine D1 receptor agonist and D2 receptor antagonist effects of the natural product (-)-stepholidine: molecular modeling and dynamics simulations. Biophysical journal 20070901
Effects of (-)-stepholidine on NMDA receptors: comparison with haloperidol and clozapine. Acta pharmacologica Sinica 20070701
Quantification of l-stepholidine in rat brain and plasma by high performance liquid chromatography combined with fluorescence detection. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070501
l-Stepholidine increases the frequency of sEPSC via the activation of D1 dopamine signaling pathway in rat prelimbic cortical neurons. Acta pharmacologica Sinica 20070501
The effect of L-stepholidine, a novel extract of Chinese herb, on the acquisition, expression, maintenance, and re-acquisition of morphine conditioned place preference in rats. Neuropharmacology 20070201
Recent developments in studies of l-stepholidine and its analogs: chemistry, pharmacology and clinical implications. Current medicinal chemistry 20070101
Effects of (-)stepholidine in animal models for schizophrenia. Acta pharmacologica Sinica 20060901
Stepholidine protects against H2O2 neurotoxicity in rat cortical neurons by activation of Akt. Neuroscience letters 20050805
Effects of l-stepholidine on forebrain Fos expression: comparison with clozapine and haloperidol. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050201
Recent pharmacological studies on natural products in China. European journal of pharmacology 20041001
(-)-Stepholidine promotes proliferation and neuronal differentiation of rat embryonic striatal precursor cells in vitro. Neuroreport 20021115
(-)-Stepholidine: a potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions. Trends in pharmacological sciences 20020101
Properties